Novavax (NVAX) Reports Q3 Loss of $3.21/sh
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $4.19 --0%
Revenue Growth %: +85.7%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Revenue Growth %: +85.7%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($3.21), versus $0.74 reported last year. Revenue for the quarter came in at $157 million versus the consensus estimate of $230.56 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- United Community Banks (UCBI) Tops Q1 EPS by 2c
- Biogen (BIIB) tops earnings expectations but revenue falls short
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
